Interpretation of Results from Tables, Graphs, and Regressions in Cancer Research

  • Raphael L. C. Araújo
  • Rachel P. Riechelmann
Chapter

Abstract

Tables and graphs are often used in clinical research articles. This chapter especially considers these items and addresses the way to create Tables and the ways to interpret graphs and curves in oncologic clinical research. Tables must present complete and clear access to data, and Figures should work as an enabler resource to better reveal interesting points in the article. The main tools used to identify associations between exposure and outcomes in clinical research are univariate regression and multivariate regression; here we describe the use of these methods. However, despite being widely used in cancer research, these tools are not easily interpreted, are sometimes overused, and may be associated with hidden biases.

Keywords

Outcomes Regressions Survival analyses Data distribution Cancer Multivariate analysis 

References

  1. 1.
    Araujo RL, Karkar AM, Allen PJ, et al. Timing of elective surgery as a perioperative outcome variable: analysis of pancreaticoduodenectomy. HPB (Oxford). 2014;16:250–62.CrossRefGoogle Scholar
  2. 2.
    Araujo RL, Gonen M, Herman P. Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis. Ann Surg Oncol. 2015;22:3070–8.CrossRefGoogle Scholar
  3. 3.
    Langer B, Bleiberg H, Labianca R, Shepherd L, Nitti D, Marsoni S, et al. Fluorouracil (FU) Plus L-leucovorin (L-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC): results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial. Proc Am Soc Clin Oncol. 2002;21:149a. Abstract 592.Google Scholar
  4. 4.
    Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J, et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol. 2006;24:4976–82.CrossRefGoogle Scholar
  5. 5.
    Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371:1007–16.CrossRefGoogle Scholar
  6. 6.
    Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative FOLFOX4 chemotherapy and sur gery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14:1208–15.CrossRefGoogle Scholar
  7. 7.
    Adam R, Bhangui P, Poston G, Mirza D, Nuzzo G, Barroso E, et al. Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg. 2010;252:774–87.CrossRefGoogle Scholar
  8. 8.
    Reddy SK, Tsung A, Marsh JW, Geller DA. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases? J Surg Oncol. 2012;105:55–9.CrossRefGoogle Scholar
  9. 9.
    Ihemelandu C, Levine EA, Aklilu M, Yacoub G, Howerton R, Bolemon B, et al. Optimal timing of systemic therapy in resect able colorectal liver metastases. Am Surg. 2013;79:422–8.Google Scholar
  10. 10.
    Araujo RL, Pantanali CA, Haddad L, et al. Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence? World J Gastrointest Surg. 2016;8:161–8.CrossRefGoogle Scholar
  11. 11.
    van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–84.CrossRefGoogle Scholar
  12. 12.
    Szumilas M. Explaining odds ratios. J Can Acad Child Adolesc Psychiatry. 2010;19:227–9.CrossRefGoogle Scholar
  13. 13.
    Araujo R, Gonen M, Allen P, et al. Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer. Ann Surg Oncol. 2013;20:4312–21.CrossRefGoogle Scholar
  14. 14.
    Bagley SC, White H, Golomb BA. Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain. J Clin Epidemiol. 2001;54:979–85.CrossRefGoogle Scholar
  15. 15.
    Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373–9.CrossRefGoogle Scholar
  16. 16.
    Ahn JO, JH K. Relationship between serum prostate-specific antigen levels and body mass index in healthy younger men. Urology. 2006;68:570–4.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Raphael L. C. Araújo
    • 1
  • Rachel P. Riechelmann
    • 2
  1. 1.Department of Upper Gastrointestinal and Hepato-Pancreato-Biliary SurgeryBarretos Cancer HospitalBarretosBrazil
  2. 2.Department of Clinical OncologyAC Camargo Cancer CenterSão PauloBrazil

Personalised recommendations